VEA
MDCO

Virtus ETF Advisers’s Medicines Co MDCO Stock Holding History

Virtus ETF Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,635
Closed -$982K – 527
2019
Q3 		$982K Sell
19,635
-3,310
-14% -$132K 0.2% 150
2019
Q2 		$837K Buy
+22,945
New +$749K 0.18% 176
2019
Q1 		– Sell
-31,840
Closed -$609K – 299
2018
Q4 		$609K Buy
31,840
+10,505
+49% +$244K 0.1% 41
2018
Q3 		$638K Buy
21,335
+1,438
+7% +$54.2K 0.07% 91
2018
Q2 		$730K Sell
19,897
-13,374
-40% -$435K 0.65% 84
2018
Q1 		$1.1M Sell
33,271
-1,946
-6% -$60.8K 0.95% 27
2017
Q4 		$963K Buy
35,217
+8,157
+30% +$251K 1.21% 30
2017
Q3 		$1M Hold
27,060
– – 0.14% 60
2017
Q2 		$1.03M Sell
27,060
-1,191
-4% -$53K 0.15% 63
2017
Q1 		$1.38M Buy
28,251
+2,717
+11% +$124K 0.25% 43
2016
Q4 		$867K Buy
25,534
+8,464
+50% +$300K 0.26% 76
2016
Q3 		$644K Buy
17,070
+2,151
+14% +$81.1K 0.31% 58
2016
Q2 		$502K Sell
14,919
-412
-3% -$14.5K 0.37% 58
2016
Q1 		$487K Hold
15,331
– – 0.67% 40
2015
Q4 		$572K Buy
+15,331
New +$579K 1.57% 25

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Virtus ETF Advisers's MDCO Position: Q4 2019 in Review

Virtus ETF Advisers sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 19,635 shares — an estimated $982K sold.

Virtus ETF Advisers first reported a position in MDCO in Q4 2015 and held it in 15 quarters. The position peaked at $1.38M in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Virtus ETF Advisers reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Virtus ETF Advisers sold 19,635 Medicines Co shares in Q4 2019, an estimated $982K.
  • Virtus ETF Advisers first reported a position in Medicines Co in Q4 2015 and held it in 15 quarters.
  • Virtus ETF Advisers's Medicines Co position peaked at $1.38M in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.